Terms: = Brain cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8 AND Diagnosis
4 results:
1. Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies.
Hunt PJ; Amit M; Kabotyanski KE; Aashiq M; Hanna EY; Kupferman ME; Su SY; Gidley PW; Nader ME; DeMonte F; Raza SM
Neurosurg Rev; 2023 Jun; 46(1):157. PubMed ID: 37386212
[TBL] [Abstract] [Full Text] [Related]
2. CEREBRAL OXIMETRY AS A PREDICTOR OF THE OUTCOME OF THE DISEASE IN PATIENTS WITH SECONDARY brain LESIONS.
Sarkulova Z; Tokshilykova A; Sarkulov M; Tleuova A; Kalieva B; Daniyarova K; Zhankulov M; Zhienalin R; Kiliptary G
Georgian Med News; 2022 Oct; (331):116-123. PubMed ID: 36539142
[TBL] [Abstract] [Full Text] [Related]
3. Transcription factor immunohistochemistry in the diagnosis of pituitary tumours.
Lenders NF; Wilkinson AC; Wong SJ; Shein TT; Harvey RJ; Inder WJ; Earls PE; McCormack AI
Eur J Endocrinol; 2021 May; 184(6):891-901. PubMed ID: 33852418
[TBL] [Abstract] [Full Text] [Related]
4. An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy.
Danjoux C; Chow E; Drossos A; Holden L; Hayter C; Tsao M; Barnes T; Sinclair E; Farhadian M
Support Care Cancer; 2006 Jan; 14(1):38-43. PubMed ID: 15856333
[TBL] [Abstract] [Full Text] [Related]
